NDC 59762-1001

Sirolimus

Sirolimus

Sirolimus is a Oral Tablet, Sugar Coated in the Human Prescription Drug category. It is labeled and distributed by Greenstone Llc. The primary component is Sirolimus.

Product ID59762-1001_26c745ce-ed4e-4b5f-9704-b6f3842c7881
NDC59762-1001
Product TypeHuman Prescription Drug
Proprietary NameSirolimus
Generic NameSirolimus
Dosage FormTablet, Sugar Coated
Route of AdministrationORAL
Marketing Start Date2014-01-07
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA021110
Labeler NameGreenstone LLC
Substance NameSIROLIMUS
Active Ingredient Strength1 mg/1
Pharm ClassesDecreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 59762-1001-1

100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1001-1)
Marketing Start Date2014-01-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59762-1001-2 [59762100102]

Sirolimus TABLET, SUGAR COATED
Marketing CategoryNDA AUTHORIZED GENERIC
Application NumberNDA021110
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-01-07
Marketing End Date2014-09-17

NDC 59762-1001-1 [59762100101]

Sirolimus TABLET, SUGAR COATED
Marketing CategoryNDA AUTHORIZED GENERIC
Application NumberNDA021110
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-01-07

NDC 59762-1001-3 [59762100103]

Sirolimus TABLET, SUGAR COATED
Marketing CategoryNDA AUTHORIZED GENERIC
Application NumberNDA021110
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-01-07
Marketing End Date2014-09-17

Drug Details

Active Ingredients

IngredientStrength
SIROLIMUS.5 mg/1

OpenFDA Data

SPL SET ID:5908cd1a-fc5a-462f-99ed-1d8983e253c9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 905158
  • 349208
  • 360110
  • UPC Code
  • 0359762100313
  • 0359762100115
  • 0359762100214
  • Pharmacological Class

    • Decreased Immunologic Activity [PE]
    • mTOR Inhibitor Immunosuppressant [EPC]
    • mTOR Inhibitors [MoA]
    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]

    Medicade Reported Pricing

    59762100101 SIROLIMUS 0.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Sirolimus" or generic name "Sirolimus"

    NDCBrand NameGeneric Name
    0904-7147sirolimussirolimus
    0904-7248SirolimusSirolimus
    13668-658SirolimusSirolimus
    16714-187sirolimussirolimus
    16714-188sirolimussirolimus
    16714-189sirolimussirolimus
    68084-956SirolimusSirolimus
    68084-915SirolimusSirolimus
    68382-520sirolimussirolimus
    70954-075SirolimusSirolimus
    50268-718SirolimusSirolimus
    55111-654SirolimusSirolimus
    55111-653SirolimusSirolimus
    59762-1002SirolimusSirolimus
    59762-1003SirolimusSirolimus
    59762-1001SirolimusSirolimus
    65841-771sirolimussirolimus
    66689-347SirolimusSirolimus
    59762-1205SirolimusSirolimus
    69238-1594SirolimusSirolimus
    60505-6197SirolimusSirolimus
    68462-682sirolimussirolimus
    68462-684sirolimussirolimus
    68462-683sirolimussirolimus
    0008-1030RapamuneSIROLIMUS
    0008-1040RapamuneSIROLIMUS
    0008-1041RapamuneSIROLIMUS
    0008-1042RapamuneSIROLIMUS

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.